[Bioavailability of a solution of digoxin in a soft gelatin capsule]. 1976

A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi

UI MeSH Term Description Entries
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005780 Gelatin A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories. Gelafusal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
January 1976, Bollettino della Societa italiana di cardiologia,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
January 1979, Arzneimittel-Forschung,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
June 1982, MMW, Munchener medizinische Wochenschrift,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
October 1976, Journal of clinical pharmacology,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
May 2019, Clinical pharmacology in drug development,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
December 1975, Clinical pharmacology and therapeutics,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
May 1978, British journal of clinical pharmacology,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
January 1979, British journal of clinical pharmacology,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
October 1978, Journal of pharmaceutical sciences,
A Marzo, and P Ghirardi, and G C Merotti, and C Gandolfi
April 1979, Journal of pharmacokinetics and biopharmaceutics,
Copied contents to your clipboard!